会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • APPARATUS FOR IN-SITU NMR SPECTROSCOPY OF METAL-AIR AND METAL-FREE AIR BATTERIES
    • 金属空气和无金属空气电池的核磁共振光谱仪器
    • WO2016114839A2
    • 2016-07-21
    • PCT/US2015057794
    • 2015-10-28
    • UNIV FLORIDA STATE RES FOUND
    • ZHENG JIAN-PINGSHELLIKERI ANNADANESH
    • G01R31/36H01M12/08
    • G01R31/3606G01N24/08H01M10/4285H01M12/08Y02E60/128
    • An apparatus for the in situ NMR monitoring of a battery including an anode, a separator and an air cathode is provided. The apparatus includes a non-metallic anode container portion, a non-metallic cathode container portion, and non-metallic connecting structure and sealing structure for connecting and sealing the anode container portion and the cathode container portion to define a hermetically sealed interior space for containing the battery with an anode of the battery adjacent the anode container portion and an air cathode of the battery adjacent the cathode container portion. The cathode container portion includes an air chamber portion with an air inlet and an air outlet. The air chamber portion can be adjacent to the air cathode such that air flowing from the air inlet to the air outlet will contact the air cathode. A method of evaluating an air cathode battery and a battery assembly for the NMR spectroscopy of an air cathode battery are also disclosed.
    • 提供了一种用于原子核磁共振监测包括阳极,分离器和空气阴极的电池的装置。 该装置包括非金属阳极容器部分,非金属阴极容器部分和用于连接和密封阳极容器部分和阴极容器部分的非金属连接结构和密封结构,以限定密封的内部空间,用于容纳 具有与阳极容器部分相邻的电池的阳极的电池和与阴极容器部分相邻的电池的空气阴极。 阴极容器部分包括具有空气入口和空气出口的空气室部分。 空气室部分可以与空气阴极相邻,使得从空气入口流到空气出口的空气将接触空气阴极。 还公开了一种评估空气阴极电池和用于空气阴极电池的NMR光谱的电池组件的方法。
    • 7. 发明申请
    • COMPOSITIONS FOR INDUCING LABOR AND ASSOCIATED METHODS
    • 用于诱导劳动者和相关方法的组合物
    • WO2009073184A1
    • 2009-06-11
    • PCT/US2008013317
    • 2008-12-03
    • UNIV FLORIDA STATE RES FOUNDOLCESE JAMES
    • OLCESE JAMES
    • A01N43/42A61K31/44
    • A61K45/06A61K31/4045A61K38/11A61K2300/00
    • The invention discloses a pharmaceutical composition containing oxytocin and melatonin in amounts therapeutically effective for inducing labor in a pregnant human patient. Preferably, the oxytocin content is reduced to mitigate unwanted side effects and the melatonin content synergistically enhances the oxytocin's labor-inducing effectiveness. Also disclosed is a pharmaceutical composition for treatment of a pregnant human patient experiencing pre-term labor characterized by early expression of melatonin receptors in myometrial cells, the composition containing one or more agents which interfere with melatonin binding to said receptors. Additionally, the invention includes a method of treatment effective in inducing labor in a pregnant human patient, the method comprising coadministering melatonin and oxytocin to the patient and a method of treating pre-term labor in a pregnant human patient manifesting early expression of melatonin receptors in her myometrial tissues, the method comprising administering to the patient an agent effective in blocking melatonin binding to the receptors.
    • 本发明公开了含有催产素和褪黑激素的药物组合物,其量在治疗有效诱导怀孕的人类患者中的劳动。 优选地,减少催产素含量以减轻不希望的副作用,并且褪黑素含量协同地增强催产素的劳动诱导效力。 还公开了一种用于治疗经历早期劳动的怀孕人类患者的药物组合物,其特征在于在子宫肌层细胞中早期表达褪黑素受体,所述组合物含有一种或多种干扰褪黑激素结合所述受体的试剂。 另外,本发明包括一种在怀孕的人类患者中有效诱导劳动的治疗方法,该方法包括将褪黑激素和催产素共同施用于患者,以及一种在怀孕的人类患者中治疗褪黑激素受体的早期表达的方法 她的子宫肌层组织,该方法包括向患者施用有效阻断结合受体的褪黑素的试剂。